Flindokalner (BMS-204352, MaxiPost) is a drug which acts as an opener of BKCa large-conductance, calcium-activated potassium channels. It was unsuccessful in clinical trials as a potential treatment for stroke, but continues to be researched for other applications such as Fragile X syndrome.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.